CTIS newsflash - 17 December 2024
Submitted by Anonymous (not verified) on 17 December 2024 - 11:34
CTIS newsflash - 17 December 2024
Q&A Clinic on post-authorisation procedure management in IRIS - 17 Jan 2025, Online, from 17 January 2025, 10:00 (CET) to 17 January 2025, 11:00 (CET)
Submitted by Anonymous (not verified) on 17 December 2024 - 10:21
Q&A Clinic on post-authorisation procedure management in IRIS - 17 Jan 2025, Online, from 17 January 2025, 10:00 (CET) to 17 January 2025, 11:00 (CET)
Q&A Clinic on post-authorisation procedure management in IRIS, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)
Submitted by Anonymous (not verified) on 17 December 2024 - 10:20
Q&A Clinic on post-authorisation procedure management in IRIS, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)
Q&A Clinic on post-authorisation procedure management in IRIS - 8 Jan 2025, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)
Submitted by Anonymous (not verified) on 17 December 2024 - 10:20
Q&A Clinic on post-authorisation procedure management in IRIS - 8 Jan 2025, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)
Human medicines European public assessment report (EPAR): Durysta, bimatoprost, Status: Withdrawn application (before opinion)
Submitted by Anonymous (not verified) on 17 December 2024 - 8:00
Human medicines European public assessment report (EPAR): Durysta, bimatoprost, Status: Withdrawn application (before opinion)
Big Data Steering Group (BDSG): 2024 report
Submitted by Anonymous (not verified) on 16 December 2024 - 15:26
Big Data Steering Group (BDSG): 2024 report
FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10
Submitted by Anonymous (not verified) on 16 December 2024 - 14:42
FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10
Medroxyprogesterone acetate
Submitted by Anonymous (not verified) on 16 December 2024 - 14:26
Medroxyprogesterone acetate
Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Date of authorisation: 23/01/2006, Revision: 20, Status: Authorised
Submitted by Anonymous (not verified) on 16 December 2024 - 14:06
Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Date of authorisation: 23/01/2006, Revision: 20, Status: Authorised
Organisation chart: Information Management
Submitted by Anonymous (not verified) on 16 December 2024 - 14:03
Organisation chart: Information Management